‌

Bioverativ

Bioverativ is a global biotechnology company developing therapies for hemophilia and other rare blood disorders, including sickle cell disease and beta-thalassemia.

Overview Structured Data Issues Contributors

bioverativ.com

bioverativ.com...ge.aspx

Is a

Organization

Company

Company attributes

Industry

Technology

Biotechnology

Biology

Regenerative medicine

Location

Waltham, Massachusetts

B2X

B2B

Pitchbook URL

pitchbook.com/profiles...169838-02

Parent Organization

Sanofi

Spun Out From

Biogen

Number of Employees (Ranges)

201 – 5000

Full Address

225 2nd Ave, Waltham, MA 02451, US0

CIK Number

1,681,6890

Place of Incorporation

Delaware

DUNS Number

0804857970

IRS Number

813,461,3100

Founded Date

2017

CAGE Code

7WTM80

Patents Assigned (Count)

Country

United States

Russia

Other attributes

Acquirer

Sanofi

Company Operating Status

Active

Public/Private

Public0

SIC Code

2,8340

Wikidata ID

Q28155329

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Bioverativ

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.